Journals / Turkish archives of otorhinolaryngology / 2020 / Cilt: 58 - Sayı: 4

Acute Presentation of Undiagnosed Hereditary Angioedema of the Larynx: Averting Death

Pages
279–281
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case report highlights the fact that delayed presentation of HAE can be life threatening and the diagnosis should be considered in all non-atopic adult patients with angioedema.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hereditary angioedema (HAE) differs from histamine-mediated angioedema in that it is resistant to steroids and antihistamines.
📊
Key Findings & Data:Laryngeal attacks of this condition, if not diagnosed timely, carry a mortality rate up to 34%.
💡
Conclusion & Impact:This case report highlights the fact that delayed presentation of HAE can be life threatening and the diagnosis should be considered in all non-atopic adult patients with angioedema.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Hereditary angioedema (HAE) differs from histamine-mediated angioedema in that it is resistant to steroids and antihistamines. Laryngeal attacks of this condition, if not diagnosed timely, carry a mortality rate up to 34%. Rarely, this disease goes undiagnosed until late adulthood and presents a life-threatening episode that poses a management challenge to the emergency physician. We report the case of a 48-yearold man who presented to the emergency department with progressive breathing difficulty two hours after consuming a carbonated drink. Clinical examination revealed supraglottic edema. He did not respond to steroids or antihistamines and required emergency tracheostomy to secure the airway due to failed intubation. Absence of symptoms such as itching or urticaria and inadequate response to steroids pointed to hereditary angioedema. Low complement factor 4 levels with low C1 esterase inhibitor functionality confirmed the diagnosis. This case report highlights the fact that delayed presentation of HAE can be life threatening and the diagnosis should be considered in all non-atopic adult patients with angioedema.

🔖

Cite This Article

RAJAN, N., SHARMA, V., PATRO, S. K., GOYAL, A. (2020). Acute Presentation of Undiagnosed Hereditary Angioedema of the Larynx: Averting Death. Turkish archives of otorhinolaryngology, Cilt: 58 - Sayı: 4, 279–281. https://ajindex.com/articles/403373

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006; 119: 267-74
  2. Longhurst HJ, Bork K. Hereditary angioedema: an update on causes, manifestations and treatment. Br J Hosp Med 2019; 80: 391-8
  3. Chen M, Riedl MA. Emerging therapies in hereditary angioedema. Immunol Allergy Clin North Am 2017; 37: 585-95
  4. Frese M, Beard N, Mere P, Katelaris C, Mills K. Interventions for the treatment of acute hereditary angioedema attacks. Cochrane Database Syst Rev [Internet]. 2019 Aug 21 [cited 2020 Jun 8]: Available from: http://doi.wiley.com/10.1002/14651858. CD013402
  5. Tarzi MD, Hickey A, Förster T, Mohammadi M, Longhurst HJ. An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema. Clin Exp Immunol 2007; 149: 513-6
  6. Magerl M, Germenis AE, Maas C, Maurer M. Hereditary angioedema with normal C1 inhibitor: update on evaluation and treatment. Immunol Allergy Clin North Am 2017; 37: 571-84
  7. Feray S, Fain O, Kayem G, Sabourdin N, Constant I, Rigouzzo A. Repeated attacks of type III hereditary angioedema with factor XII mutation during pregnancy. Int J Obstet Anesth 2018; 36: 114-8
  8. Gompels MM, Lock RJ, Morgan JE, Osborne J, Brown A, Virgo PF. A multicentre evaluation of the diagnostic efficiency of serological investigations for c1 inhibitor deficiency. J Clin Pathol 2002; 55: 145-7
  9. Otani IM, Banerji A. Acquired C1 Inhibitor Deficiency. Immunol Allergy Clin North Am 2017; 37(3): 497-511
  10. Patel G, Pongracic JA. Hereditary and acquired angioedema. Allergy Asthma Proc 2019; 40(6): 441-5
  11. Gower RG, Busse PJ, Aygören-Pürsün E, Barakat AJ, Caballero T, Davis-Lorton M, et al. Hereditary angioedema caused by c1-esterase inhibitor deficiency: a literature-based analysis and clinical commentary on prophylaxis treatment strategies. World Allergy Organ J 2011; 4: S9-21
  12. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992; 71: 206-15.